OTCPK:BHHKF - Post by User
Post by
OneTwoOneTwoon Jun 10, 2019 6:25pm
52 Views
Post# 29813288
OH BOY
OH BOYLooks like Benchmark Botanics doesn't have the expertise afterall for the Chinese pharma deal. Seems like the only currency they have is the illusion that they can leverage their existing license for other comapnies to get their own licenseing. Explain how this works when Potanicals can't maintain their own sales license? Health Canada is pretty clear on each application being judged on it's own merits and not extensions of existing licenses. Those days are long gone. This is about as sad as it gets. lol
https://stockhouse.com/news/press-releases/2019/06/10/eastwest-bioscience-signs-letter-of-intent-with-benchmark-botanics